Last edition
News about "Stelara Biosimilar Approval"
Biocon Expands Yesintek Biosimilar Market Access Globally
Biocon has secured market entry for Yesintek, its proposed Stelara biosimilar, in additional global markets, building on existing agreements with Janssen.
Stelara Biosimilar Approval | 26/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members